Jose Luis Maldonado-García

Dr. Jose Luis Maldonado-García

Bioquímica, Facultad de Medicina, UNAM, Mexico City, Ciudad de México, Mexico
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2020 in Frontiers in Endocrinology
Verified
Journal Article
Open access
PDF file
SASamantha Alvarez-Herrera
Samantha Alvarez-Herrera
RERaúl Escamilla
Raúl Escamilla
OMOscar Medina-Contreras
Oscar Medina-Contreras
RSRicardo Saracco
Ricardo Saracco
YFYvonne Flores-Medina
Yvonne Flores-Medina
Lenin PavónLenin Pavón
Lenin Pavón
Atypical antipsychotics (AAP) or second-generation antipsychotics are the clinical option for schizophrenia treatment during acute psychoses, but they are also indicated for maintenance during lifetime, even though they are being used for other psychiatric conditions in clinical practice such as affective disorders and autism spectrum disorder, among others. These drugs are differentiated from typical antipsychotics based on their clinical profile and are a better choice because they cause fewer side effects regarding extrapyramidal symptoms (EPS). Even though they provide clear therapeutic benefits, AAP induce peripheral effects that trigger phenotypic, functional, and systemic changes outside the Central Nervous System (CNS). Metabolic disease is frequently associated with AAP and significantly impacts the patient's quality of life. However, other peripheral changes of clinical relevance are present during AAP treatment, such as alterations in the immune and endocrine systems as well as the intestinal microbiome. These less studied alterations also have a significant impact in the patient's health status. This manuscript aims to revise the peripheral immunological, endocrine, and intestinal microbiome changes induced by AAP consumption recommended in the clinical guidelines for schizophrenia and other psychiatric disorders.

19 August 2020 in World Journal of Psychiatry
Verified
Journal Article
Open access
FPFrancisco Rafael de la Peña
Francisco Rafael de la Peña
CCCarlos Cruz-Fuentes
Carlos Cruz-Fuentes
LPLino Palacios
Lino Palacios
Manuel Iván Girón-PérezManuel Iván Girón-Pérez
Manuel Iván Girón-Pérez
EMEmilio Medina-Rivero
Emilio Medina-Rivero
Lenin PavónLenin Pavón
Lenin Pavón
Serum levels of chemokines in adolescents with major depression treated with fluoxetine

28 January 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Priscila Samantha Alvarez-HerreraPriscila Samantha Alvarez-Herrera
Priscila Samantha Alvarez-Herrera
MVMauricio Rosel Vales
Mauricio Rosel Vales
Gilberto Pérez--SánchezGilberto Pérez--Sánchez
Gilberto Pérez--Sánchez
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
YFYvonne Flores-Medina
Yvonne Flores-Medina
Lenin PavónLenin Pavón
Lenin Pavón
Dopamine and serotonin receptors and transporters play an essential role in the pathophysiology of schizophrenia; changes in their expression have been reported in neurons and leukocytes. Each antipsychotic induces a unique pattern in leukocyte function and phenotype. However, the use of polytherapy to treat schizophrenia makes it challenging to determine the specific effects of risperidone on peripheral blood mononuclear cells (PBMCs). The aim of this study was to evaluate the changes in the expression of D3, D5, DAT, 5-HT2A, and SERT in PBMCs from healthy volunteers (HV), drug-naive patients with schizophrenia (PWS), drug-free PWS, and PWS treated with risperidone for up to 40 weeks using quantitative PCR. Our study revealed elevated mRNA levels of D3, DAT, 5-HT2A, and SERT in unmedicated PWS. Treatment with risperidone led to a reduction only in the expression of 5-HT2A and SERT. Furthermore, we observed a moderate correlation between 5-HT2A expression and the positive and negative syndrome scale (PANSS), as well as SERT expression and PANSS scale. We also found a moderate correlation between 5-HT2A and SERT expression and the positive subscale. The duration of risperidone consumption had a significant negative correlation with the expression of 5-HT2A and SERT. Our study introduces the measurement of 5-HT2A and SERT expression in PBMCs as a useful parameter for assessing the response to risperidone in PWS.

11 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
Jose Luis Maldonado-GarcíaJose Luis Maldonado-García
Jose Luis Maldonado-García
Gilberto Pérez--SánchezGilberto Pérez--Sánchez
Gilberto Pérez--Sánchez
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
Priscila Samantha Alvarez-HerreraPriscila Samantha Alvarez-Herrera
Priscila Samantha Alvarez-Herrera
Lenin PavónLenin Pavón
Lenin Pavón
MMMartha Moreno-Lafont
Martha Moreno-Lafont
Brucellosis is a zoonosis affecting 50,000,000 people annually. Most patients progress to a chronic phase of the disease in which neuropsychiatric symptoms upsurge. The biological processes underlying the progression of these symptoms are yet unclear. Peripheral inflammation mounted against Brucella may condition neurochemical shifts and hence unchained neuropsychiatric disorders. Our work aimed at establishing whether neurological, behavioral, and neurochemical disarrays are circumstantially linked to peripheral inflammation uprise secondary to Brucella abortus 2308 infections. We then evaluated, in control and Brucella-infected mice, skeletal muscle strength, movement coordination, and balance and motivation, as well as dopamine, epinephrine, norepinephrine, and serotonin availability in the cerebellum, frontal cortex, and hippocampus. Serum levels of proinflammatory cytokines and corticosterone in vehicle-injected and -infected mice were also estimated. All estimates were gathered at the infection acute and chronic phases. Our results showed that infected mice displayed motor disabilities, muscular weakness, and reduced motivation correlated with neurochemical and peripheral immunological disturbances that tended to decrease after 21 days of infection. The present observations support that disturbed peripheral inflammation and the related neurochemical disruption might lead to mood disorders in infected mice. Future experiments must be aimed at establishing causal links and to explore whether similar concepts might explain neurological and mood disorders in humans affected by brucellosis.

15 May 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
Jose Luis Maldonado-GarcíaJose Luis Maldonado-García
Jose Luis Maldonado-García
Priscila Samantha Alvarez-HerreraPriscila Samantha Alvarez-Herrera
Priscila Samantha Alvarez-Herrera
Gilberto Pérez--SánchezGilberto Pérez--Sánchez
Gilberto Pérez--Sánchez
Enrique Becerril VillanuevaEnrique Becerril Villanueva
Enrique Becerril Villanueva
Lenin PavónLenin Pavón
Lenin Pavón
MMMartha Moreno-Lafont
Martha Moreno-Lafont
Brucellosis is an infection widely distributed around the world, and in some countries it is considered a public health problem. Brucellosis causes insidious symptoms that make it difficult to diagnose. Infection can also trigger chronic pain and neuropsychiatric complications. Antibiotics are not always effective to eradicate infection, contributing to chronicity. We aimed to investigate the effects of antibiotic treatment on proinflammatory cytokines, neurotransmitters, corticosterone, and behavior in a murine model of infecrion of B. abortus strain 2308. Four study groups were created: (a) control; (b) antibiotic control; (c) infected with B. abortus 2308; and (d) infected and treated with rifampicin and doxycycline. We determined B. abortus 2308 colony-forming units (CFUs), the count of dendritic cells, and macrophages in the spleen; serum levels of cytokines and corticosterone; levels of serotonin, dopamine, epinephrine, and norepinephrine in the brain; and equilibrium, physical strength, anxiety, and hopelessness tests. The infected and treated mice group was compared with the control and infected mice to assess whether treatment is sufficient to recover neuroimmunoendocrine parameters. Our results showed that despite the treatment of brucellosis with rifampicin and doxycycline, antibiotic-treated mice showed a persistence of B. abortus 2308 CFUs, an increased count in macrophage number, and higher circulating levels of corticosterone. Furthermore, the levels of IL-12, IL-6, and TNF-α remained higher. We found a decrease in muscular strength and equilibrium concomitant to changes in neurotransmitters in the hippocampus, cerebellum, and frontal cortex. Our data suggest that the remaining bacterial load after antibiotic administration favors inflammatory, neurochemical, and behavioral alterations, partly explaining the widespread and paradoxical symptomatology experienced by patients with chronic brucellosis.

8 November 2022 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
AMAdriana I. Muñoz
Adriana I. Muñoz
Jose Luis Maldonado-GarcíaJose Luis Maldonado-García
Jose Luis Maldonado-García
AFAna Fragozo
Ana Fragozo
Luis Vallejo-CastilloLuis Vallejo-Castillo
Luis Vallejo-Castillo
ALAmellalli Lucas-Gonzalez
Amellalli Lucas-Gonzalez
SPSonia Mayra Pérez-Tapia
Sonia Mayra Pérez-Tapia
Neutrophil-to-lymphocyte ratio (NLR) is a cheap and easy-to-obtain biomarker that mirrors the balance between innate and adaptive immunity. Cortisol and catecholamines have been identified as major drivers of NLR. High cortisol levels increase neutrophils while simultaneously decreasing lymphocyte counts. Likewise, endogenous catecholamines may cause leukocytosis and lymphopenia. Thus, NLR allows us to monitor patient severity in conditions such as sepsis. Twenty-six puppies with sepsis secondary to canine parvoviral enteritis were treated with and without an immunomodulator. Our group determined the NLR and the plasmatic cortisol levels by chemiluminescence, and norepinephrine (NE) and epinephrine (E) by HPLC during the first 72 h of clinical follow-up. Our results showed that at admission puppies presented an NLR value of 1.8, cortisol of 314.9 nmol/L, NE 3.7, and E 3.3 pmol/mL. Both treatments decreased admission NLR values after 24 h of treatment. However, only the puppies treated with the immunomodulator (I) remained without significant changes in NLR (0.7–1.4) compared to the CT group, and that showed a significant difference (P < 0.01) in their NLR value (0.4–4.6). In addition, we found significant differences in the slope values between the admission and final values of NLR (P < 0.005), cortisol (P < 0.02), and E (P < 0.05) between treatments. Then, our data suggest that the immunomodulator positively affects the number of lymphocytes and neutrophils involved in NLR as well as major drivers like cortisol and epinephrine, which is reflected in clinical parameters and survival.